AI is improving idiopathic pulmonary fibrosis care
The integration of AI into the management of IPF represents a significant advancement in the field.
Themes
Sartorius to invest $3m for minority share in biotech start-up Nanotein
New US-EU trade deal on tariffs ends pharma’s geopolitical immunity
African countries plan shift to healthcare funding autonomy amid aid cuts
Quantum leap or quantum hype: the role of quantum computing in protein modelling
Can rare disease research in the US thrive under the new administration?
Ultragenyx receives complete response letter for UX111 BLA
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
